A New Anti-Diabetes Drug as a Novel Therapy for Ovarian Cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1099375

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

New treatments are urgently needed to improve the chances of survival for patients diagnosed with high grade epithelial ovarian tumours. This project will investigate the application of a new class of anti-diabetes medications as an adjunct therapy for cancer patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $711,966.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chemokines | immunosuppression | insulin resistance | mouse models | ovarian cancer

Related Links